🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is part of the ADAPT Forward platform study (NCT07294170). ADAPT...
Status
Recruiting
Location
Visionary Investigators Network
Start Date
2026-07-10
Trial ID
NCT07673627
Treatments Being Tested
This study plans to learn more about if the drug efgartigimod can be used i...
Status
Recruiting
Location
University of Colorado
Start Date
2025-03-06
Trial ID
NCT06860633
Treatments Being Tested
A phase 1 study in healthy volunteers (female and male) to evaluate through...
Status
Completed
Location
Multiple Locations
Start Date
2015-09-09
Trial ID
NCT03457649
The study is a Randomized, Open-label, Parallel Group Study to Compare the ...
Status
Completed
Location
QPS Netherlands B.V.
Start Date
2017-10-11
Trial ID
NCT03334084
Treatments Being Tested
The primary purpose of this study is to measure the efficacy and safety of ...
Status
Active Not Recruiting
Location
HonorHealth Neurology - Bob Bove Neuroscience Institute
Start Date
2024-04-16
Trial ID
NCT06298552
Treatments Being Tested
The primary purpose of this study is to evaluate the efficacy of ublituxima...
Status
Recruiting
Location
TG Therapeutics Investigational Trial Site
Start Date
2026-07-30
Trial ID
NCT07673744
Treatments Being Tested
The main purpose of this study is to confirm the correct dose of efgartigim...
Status
Recruiting
Location
Centre Hospitalier Universitaire de Bordeaux Groupe Hospitalier Pellegrin Hopital des Enfants
Start Date
2025-10-20
Trial ID
NCT07194850
Treatments Being Tested
Efgartigimod in Myasthenic Crisis Background Myasthenia gravis (MG) is a pr...
Status
Not Yet Recruiting
Location
Rambam- Department of Neurology
Start Date
2024-11-15
Trial ID
NCT06688253
Treatments Being Tested
This study will compare the pharmacodynamics, pharmacokinetics and safety o...
Status
Completed
Location
Study Site 1
Start Date
2020-08-18
Trial ID
NCT04564066
Treatments Being Tested
To evaluate the efficacy and safety of efgartigimod IV in Chinese patients ...
Status
Terminated
Location
Peking University People's Hospital
Start Date
2023-02-20
Trial ID
NCT05810961
Treatments Being Tested